[Abstract] The main purpose of this sophisticated and highly versatile method is to visualize and quantify structural vessel wall properties, cellular recruitment, and lipid/dextran extravasation under physiological conditions in living arteries. This will be of interest for a broad range of researchers within the field of inflammation, hypertension, atherosclerosis, and even the pharmaceutical industry. Currently, many researchers are using in vitro techniques to evaluate cellular recruitment, like transwell or flow chamber systems with cultured cells, with unclear physiological comparability. The here introduced method describes in detail the use of a sophisticated and flexible method to study arterial wall properties and leukocyte recruitment in fresh and viable murine carotid arteries ex vivo under arterial flow conditions. This model mimics the in vivo situation and allows the use of cells and arteries isolated from two different donors (for example, wildtype vs. specific knockouts) to be combined into one experiment, thereby providing information on both leukocyte and/or endothelial cell properties of both donors. As such, this model can be considered an alternative for the complicated and invasive in vivo studies, such as parabiotic experiments.
has been used in several scientific publications, for example to show cell recruitment under control and inflammatory conditions (Schmitt et al., 2014) , chemokine presence (Soehnlein et al., 2011) , detection of smooth muscle cells (Subramanian et al., 2010; Spronck et al., 2016) or proliferating endothelial cells (Schober et al., 2014) , endothelial protein depositions (Ortega-Gomez et al., 2016), adhering platelets (Karshovska et al., 2015) , atherosclerotic lesions in the bifurcation 2008 ; Weber et al., 2011) , visualization of the endothelial glycocalyx (Reitsma et al., 2011) , or evaluation of extracellular matrix markers (Boerboom et al., 2007; .
TPLSM imaging can be performed prior-, during-, and/or post-perfusion. The settings of the microscope system strongly depend on the available microscope. We utilize a modern Leica SP5II MP system with a 20x WD objective and a Ti:Sa pulsed laser which allows 4 channel imaging at video rate. This is however not a requirement for application of this method as older, less well equipped TPLSM systems also suffice.
In recent years, we have further advanced the method, making it applicable to investigate recruitment of specific cell-types to the viable carotid artery (Döring et al., 2014; Schmitt et al., 2014; Karshovska et al., 2015) . Not only does this method enable the user to specifically and simultaneously investigate recruitment of various cell types like monocytes, neutrophils or T-cells to highly physiological endothelium by differential fluorescent labeling (using cell trackers or equivalent), it also allows us to combine specific arteries and cells isolated (blood, bone marrow) from different (wildtype vs. knockout) mouse subsets. As a result, a system is created that can define whether effects on recruitment are mediated by the vascular and/or haematopoietic deficiency. Besides the functional readout of cell recruitment, the method further enables simultaneous or subsequent labelling and subcellular resolution imaging of vascular structures and presence of compounds in the vessel wall. As a result, altered adhesion may directly be linked to the presence or absence of specific targets.
By simultaneous application of various fluorescently labeled leukocyte subsets, the experimental conditions are equal for each cell-type, thereby limiting the experimental variation due to for example flow pattern differences (data may be presented in absolute numbers or ratios). The latter also limits the number of experiments required and, in combination with a reduced number of necessary experimental animals because inflammatory cells and arteries can be isolated from the same animals, ultimately the method reduces the number of required animals.
In addition to the cell recruitment assay we have developed an application using fluorescently labeled low-density lipoprotein particles or dextrans to visualize and quantify lipid or dextran extravasation in 1. 50 ml tubes (3 x 
Procedure

A. Isolation of carotid arteries
Isolate the mouse carotid arteries (length after isolation preferably 3-6 mm) following the local ethical committee guidelines using a stereo microscope (see Equipment A5) and place them in HBBS (pH 7.4) in a polystyrene dish (Ø 35 mm) (see Figure 1 for detailed information).
www.bio-protocol.org/e2344 Hold the dissected artery by one of both outer end (Dumont forceps) and place it into a small dish filled with HBSS to keep it moist. After isolation the artery must be kept cool (fridge or ice) until further processing.
There are some prerequisites to be met which are crucial for maintaining arterial viability and TPLSM imaging:
1. Mechanical damage either by pinching or overstretching the vessel must be avoided at all cost as this will immediately result in altered structural and functional behaviour.
2. Contact of air with the artery should be minimized. Isolate the artery while keeping the wound moist at all time, after dissection quickly transfer the artery into medium.
3. The artery must be very clean for imaging. Any 'dirt', hair, or tissue on the outside of the artery will result in loss of visibility of the parts of the artery underneath it. So work meticulously and also remove thin sheets of connective tissue which are covering the artery. 3. Flush the bone with HBSS into a 50 ml tube by using a 27 G needle and 10 ml syringe.
Note: It is important that all bone marrow cells are removed from the bones. Use as much volume as needed for flushing until practically all cells (red colour) are removed.
4. Prepare a single cell solution by resuspending the cells using a 1 ml pipette.
5. Filter the resuspended bone marrow cells with a 50 µm cell strainer to reduce tissue in the final cell suspension.
6. Centrifuge the cells for 5 min at 300 x g.
7.
Resuspend the pellet with 5 ml of lysis buffer (in order to lyse the red blood cells) and incubate for 1 min at room temperature. 12. Wash the cells in suspension twice after the staining procedure, resuspend in 3 ml HBSS, use 50 ml tubes, centrifuge at 300 x g for 5 min.
www.bio-protocol.org/e2344 14. Mix both types of leukocytes (2 different subsets or sources, labelled with different colours to distinguish them from each other) to achieve a 1:1 ratio of both resuspended in a total of 6 ml HBSS.
15. Cell density for each leukocyte group should be 1.5 x 10 6 leukocytes (thus, the total number of cells in suspension for each flow assay is 3 x 10 6 in 6 ml HBSS).
16. Analyse the resulting leukocyte suspension by flow cytometry in order to confirm the 1:1 ratio.
C. Preparation of arteriography chamber 2. Etch the tips of the grinded pipettes by NH4HF2 or NH4F
.
HF compound to the tip of the grinded pipettes (one can simply hold the tip several mm in the compound in the opened storage flask).
(10-20 min or when the etching process was successful), rinse carefully with distilled water after the procedure, and let them dry (RT). Etched tips enable more stable tying of the artery to the glass.
www.bio-protocol.org/e2344 3. Cut the 14 G needles by making a circular edge using a small file and then breaking the tip off using small pincers and remove any sharp edges using sandpaper. The needles should have a length of 40 mm and 50 mm (50 mm for the adjuster side of the chamber).
4. Glue the glass pipettes into the shortened and blunt 20 G needles using silicone kit. Make sure the space between the glass and the steel needle is fully closed to ensure air tightness of the construct. Moreover, make sure the non-sharpened outer edge of the glass pipette just reaches the Luer-lock connector of the 20 G needle in order to avoid accumulation of debris in the nonfilled space within the construct. 
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artery is straight at 80 mmHg. Note the length difference between the artery in Procedure E and Procedure G, where a pressurized artery at 80 mmHg is approximately 30% longer.
5. Place two or three threads over the pipette using the stereomicroscope (see Equipment A5).
6. Mount the common part of the carotid by pulling it over the pipette at the length adjuster side of the chamber (Not too far!).
7. Tighten the two or three threads so that the artery is fixed in between the glass tip and the threads.
8. Gently flush some medium through the carotid in order to get rid of possible blood leftovers.
Note: It is preferred to flush the artery inside the chamber and not flush the mouse as a total in order to limit air in the lumen. This however has to be done quickly (within 30 min) after carotid isolation in order to avoid blood clots!
9. Adjust the distance between both pipettes using the adjuster on the outside of the chamber ( Figure 4B ; green).
10. Place two or three threads over the 2 nd pipette.
11. Mount the bifurcation side of the carotid by pulling it over the pipette ( Figure 4B ). Make sure you have tightened all branches that are not cannulated to create a closed circuit.
Notes: Make sure you mount the artery in its physiological direction for the flow assay, i.e., flow goes from common to bifurcation. A failure of the flow direction will result in false-positive or negative results. Also make sure the artery is not mounted under tension due to twisting of the artery!
12. Open the 3-way tab on the exit side (the non-length adjustment side of the chamber) and gently flush some medium to see whether pipettes are open (HBSS runs through the artery and comes out on the exit side) and artery is mounted stably.
13. Connect the sphygmomanometer with 3 x 1 mm silicone tubing and a female Luer-connector to the length adjustment side of the chamber and fill the 3 x 1 mm tubing of the manometer with some HBSS.
14. Adjust the 3-way connectors to create a closed circuit that can be pressure controlled using the manometer and stepwise increase the average intraluminal pressure while adjusting the length of the unfolding vessel using the external adjuster until you reach 100 mmHg. Be aware of leaks of the mounted artery by tracking the medium level in the 3 x 1 mm silicone tube connected to the sphygmomanometer. 16. When all is correctly mounted, proceed to the next step.
E. Two-photon laser scanning microscopy (TPLSM) www.bio-protocol.org/e2344 2. Turn on the system according to protocol (different for every microscope).
3. Place the perfusion chamber onto the microscope stage and focus on the carotid artery using the 20x 1.00 WD objective, the fluorescent light source and the RGB-filter. 8. Select the Z-range (total thickness of the imaged volume).
Note: Be very careful not to focus too deep as this will result in destruction of
9. Start the selected scan using the 'record' function.
10. Record as many datasets as required.
11. When ready with imaging make sure to rename and save the generated data.
12. Copy the data to one of the processing computers. 2. Remove the 3-way connector on the inlet side.
3. Remove any air from the inlet Luer-connector (using a 1 ml syringe filled with HBSS with a 14 G needle) of the pipette.
4. Slowly inject mounted vessels with 50 µg/ml Dil-LDL, diluted in HBSS using a 1 ml syringe.
Note: DiI is a fluorescent lipophilic tracer attached to LDL with an excitation of 549 nm and
emission of 565 nm.
5. Re-pressurize the artery to 80 mmHg using the sphygmomanometer.
6. Place the sphygmomanometer outside on top of the climate box and keep an eye on it while imaging. A drop in pressure means that the system is not completely closed and therefore leaky.
7. Place the mounted artery on the microscope stage inside the climate box.
8. Incubate for 90 min at 37 °C.
9. Perfuse the vessel with HBSS to wash away non-bound LDL (similar procedure as previously described injection of Dil-LDL).
10. Inject anti-CD31 eFluor450 antibody (labeling endothelial cells, more specifically endothelial junctions): same procedure as previously described injection of Dil-LDL.
11. Incubate for 10 min at 37 °C.
12. Perfuse the vessel with HBSS to wash away non-bound antibody (similar procedure as previously described injection of Dil-LDL), re-pressurize and place it again on the microscope stage.
Note: Flushing or loading of the vessel is best performed outside the climate chamber with help
of a stereomicroscope.
Start recording (see image acquisition section above).
www.bio-protocol.org/e2344 1. Connect the flow chamber with the common carotid artery side to the syringe pump using a 10 ml syringe, a male Luer-connector, a 3-way tab, 3 x 1 mm silicone tubing (1 m), and a female Luer-connector (from the syringe to the 3-way connector attached to the chamber). The pump can be placed on top of or next to the climate chamber and should be tilted slightly to make sure the syringe empties completely. Use some extra length of 3 x 1 mm silicone tubing (1 m) and make a loop inside the climate chamber (with durapore tape) in order to preheat the medium or cell suspension to 37 °C before it reaches the artery.
2. Make sure the whole system is air-free and filled with HBSS before attaching it to the artery! 3. Connect the exit side of the vessel/chamber to the water column using another 3-way tab and 7. Change the syringe with a similar one containing the pre-prepared cell suspension mix. Make the Luer-connector and 3-way tab air free using a 14 G needle and an HBSS filled 1 ml syringe.
Apply a total volume of 6 ml of cell suspension mix, which allows for a flow time of 10 min. 
Data analysis
A. Analyses of Dil-LDL extravasation 1. Quantification of the number and size of junctional Dil-LDL particles per cell was performed using Leica LASX 3.11 software.
www.bio-protocol.org/e2344 2. Recorded xyz-stacks were recombined into maximum intensity projections, transforming the 3D information into a resultant 2D image showing all cell junction in the xy-plane ( Figure 7A ). 6. The polyline selection was used to generate intensity profiles ( Figure 7B ).
7.
A threshold of the Dil-LDL channel was set just above the background intensity to exclude background noise.
Note:
The specific threshold level will vary depending on the experimental background level and has to be determined individually.
8. The total number of individual peaks in the intensity profile represented the number of particles, the full width of each peak was used to estimate the size of junctional Dil-LDL particles. 
